• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Veranova: A CDMO that manages complexity with confidence.
    All News #Library
    Biotech

    Novo Seeks Obesity Refresh with $550 M Replicate Deal

    FIERCE BIOTECH

    AbbVie-Partnered Protein Degrader Specialist Plexium raises $60M

    FIERCE BIOTECH

    J&J Drops Development of Arthritis Drug After Trial Setback

    REUTERS

    Fired CDC director clashed with Kennedy on vaccine policy

    REUTERS

    Cantargia Granted Important US Patent for Nadunolimab

    ACCESSWIRE

    Pfizer, Moderna score updated COVID Vaccine Approvals From FDA

    FIERCE PHARMA

    Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier

    BIOSPACE

    RemeGen`s Telitacicept Result sets up IgAN Submission in China

    FIERCE PHARMA

    ZHEN-AO Trial: 5`-Nucleotide Cuts DNA Methylation Age by 3.08 Yrs

    BUSINESSWIRE

    CAGE Bio, Partner to Advance GvHD Cutaneous Treatments

    PR NEWSWIRE

    Nautilus Biotech to Present at September Investor Conferences

    GLOBENEWSWIRE

    Wugen Secures $115M for Advancing WU-CART-007 CAR-T Therapy

    GLOBENEWSWIRE

    Veracyte Announces New Study Published Metastatic Prostate Cancer

    BUSINESSWIRE

    TREOS, Charité, Junshi Launch Ph2 Trial in MSS Colorectal Cancer

    GLOBENEWSWIRE

    Tevogen Bio Unveils Assets, Plans Valuation Disclosure

    GLOBENEWSWIRE

    Skye Bio to Host KOL Event on CBeyond Ph2a Topline Data

    GLOBENEWSWIRE

    Shineco Acquires BICC, Boosts RWA Ecosystem for Growth

    PR NEWSWIRE

    Regeneron Plans 2026 FDA Filing for siRNA Myasthenia Gravis Drug

    BIOSPACE

    Rapt Therapeutics to Join Investor Conferences

    GLOBENEWSWIRE

    ProKidney to Participate in Two Upcoming Conferences

    GLOBENEWSWIRE

    Opus Genetics Showcases Inherited Retinal Disease Programs

    GLOBENEWSWIRE

    Oncoinvent ASA Advances Phase 2 Ovarian Cancer Program

    PR NEWSWIRE

    Nuvation Bio to Participate in Upcoming Investor Conferences

    BUSINESSWIRE

    Novavax`s Nuvaxovid™ COVID-19 Vaccine FDA Approved in US

    PR NEWSWIRE

    Northwest Biotherapeutics to Acquire Advent BioServices Ltd

    PR NEWSWIRE

    Myriad Genetics to Present at Investor Healthcare Conferences

    GLOBENEWSWIRE

    MS Pharma Launches Biologics Plant in Saudi Arabia

    PR NEWSWIRE

    Moleculin Issues New Positive AML Overall Survival Data:

    GLOBENEWSWIRE

    Minovia Gets $350K Grant to Develop Mitochondria Biomarkers

    GLOBENEWSWIRE

    Maxion Therapeutics Appoints Dr. Santiago Arroyo to Board

    GLOBENEWSWIRE

    Maia Biotechnology Publishes Interim Data on Telomere-Targeting

    GLOBENEWSWIRE

    Lexicon Pharmaceuticals to Present at Investor Conferences

    GLOBENEWSWIRE

    Leal Raises $30M Series A for Neuro-Metabolic Therapies

    PR NEWSWIRE

    Jasper Therapeutics to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    Innovent Announces 2025 Interim Results and Business Updates

    PR NEWSWIRE

    ImmunoPrecise Advances Universal Dengue Vaccine to Preclinical

    BUSINESSWIRE

    Hope Bio Gets FDA RMAT for Multiple Sclerosis Stem Cell Therapy

    BUSINESSWIRE

    HitGen Launches OpenDEL™ 5.0 for Enhanced Research Technology

    PR NEWSWIRE

    Nykode Bets Future on Cancer Trial After Losing Genentech Pact

    FIERCE BIOTECH

    FORE Bio to Participate in Upcoming Investor Conferences

    BUSINESSWIRE

    Foghorn Therapeutics to Present at Three Investor Conferences

    GLOBENEWSWIRE

    Flare Therapeutics to Present at September Investor Conferences

    GLOBENEWSWIRE

    FibroBiologics to Present at HC Wainwright Investment Conference

    GLOBENEWSWIRE

    Faron Pharmaceuticals Ltd Reports Half-Year Financial Results

    PHARMAWEB

    ExCellThera`s Blood Cancer Cell Therapy Zemcelpro Earns EU Nod

    PR NEWSWIRE

    Evommune Starts Phase 2b Trial for Oral MRGPRX2 Antagonist

    PR NEWSWIRE

    Evaxion to Present at Multiple Conferences in H2 2025

    GLOBENEWSWIRE

    Lilly Answers Novartis Breast Cancer Rivalry with Survival Win

    FIERCE PHARMA

    Lilly’s Verzenio Extends Survival in HR+, HER2- Breast Cancer

    PR NEWSWIRE

    Editas Medicine to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Disc Medicine to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Design Therapeutics to Present at 2025 Cantor Global Conference

    GLOBENEWSWIRE

    HERTHENA-Breast04 Ph3 Starts for Patritumab Deruxtecan in Cancer

    BUSINESSWIRE

    clock.bio Names Ex-BioNTech Exec Dr. Boehler as CBO

    PR NEWSWIRE

    Celcuity to Submit Gedatolisib NDA for HR+/HER2- Breast Cancer

    GLOBENEWSWIRE

    Cabaletta Bio to Present at September Investor Conferences

    GLOBENEWSWIRE

    Biontech Reveals CEO John Crowley as Key Speaker at iC³® Summit

    GLOBENEWSWIRE

    EC Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC

    BUSINESSWIRE

    Avidity Biosciences Joins Investor Conferences

    PR NEWSWIRE

    Avance Clinical Speeds Milestones for 700+ Emerging Biotechs

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.